To include your compound in the COVID-19 Resource Center, submit it here.

Sepracor, Arrow International Group deal

Sepracor received an exclusive, worldwide license to use Arrow's stable steroid suspension formulations and other nebule technology to develop and commercialize inhaled therapeutics containing ciclesonide,

Read the full 256 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE